动脉样硬化中的对称性和不对称性
Oliwia Kolaszyńska1, Jacek Lorkowski2
1Asklepios Klinikum Uckermark, Schwedt, Germany (I Department of Internal Medicine).
概括
血管对称性和不对称性显著影响动脉样硬化发展和进展. 人工智能 (AI) 为心血管风险评估提供了新的精准医学方法,改进了现有的尺度.
科学领域:
- 心血管医学 心血管医学
- 生物医学工程 生物医学工程
- 医疗信息学 医疗信息学
背景情况:
- 动脉样硬化是全球主要的死亡原因.
- 血液动力学,血管和斑块对称性/不对称性是动脉样硬化的关键因素.
- 现有的心血管风险尺度需要改进.
研究的目的:
- 审查关于动脉样硬化的血管系统对称性和不对称性的作用.
- 通过使用精准医学原则,引入一种新的心血管风险评估方法.
- 突出人工智能 (AI) 在心血管风险分层中的重要性.
主要方法:
- 对PubMed和MEDLINE数据库的文献分析,寻找与血管对称性和动脉样硬化相关的术语.
- 审查当前关于血液动力学,斑块分布和动脉几何学的研究.
- 探索人工智能在心血管风险的精密医学中的应用.
主要成果:
- 数据库搜索显示了大量关于与动脉样硬化,动脉狭窄和动脉样硬化病变相关的对称性/不对称性的文献.
- 这项研究强调了血管对称性和不对称性在动脉疾病中的关键作用.
- 人工智能解决方案正在成为开发先进心血管风险评估工具的强大工具.
结论:
- 了解血管对称性和不对称性对于诊断和管理诸如动脉样硬化等动脉疾病至关重要.
- 人工智能对于未来的心血管风险分层是不可或缺的,与精准医学保持一致.
- 整合人工智能有望提供更准确和个性化的心血管风险评估.
相关概念视频
Atherosclerosis I: Introduction
9
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
11
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
11
Asymmetric Lipid Bilayer
7.3K
Biological membranes show uneven distribution of different types of lipids in the inner and outer layers, resulting in transverse asymmetric membranes. The treatment of the erythrocyte membrane with the enzyme phospholipase confirmed the asymmetric nature of the lipid bilayer. The enzyme hydrolyzes lipids into fatty acids and hydrophilic groups. The phospholipase acts only on the outer layer of the membrane, while the inner layer remains intact. The phospholipase treatment resulted in 80%...
7.3K
Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Inflammation
53.7K
Overview
53.7K


